Skip to main
OPCH

OPCH Stock Forecast & Price Target

OPCH Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 20%
Buy 40%
Hold 40%
Sell 0%
Strong Sell 0%

Bulls say

Option Care Health is currently facing challenges in capturing leverage in its operating costs, but with planned cost management initiatives and optimization of procurement activities, the company is still expected to achieve its 2026 financial guidance. The company's 2026 gross margin percentage is likely to experience a slight lift due to its faster revenue growth in acute therapy. Despite potential risks in the specialty pharmacy space, the extreme share price weakness offers an excellent buying opportunity for investors with a long-term horizon as the company is well-positioned to compete and is expected to see top-line growth and margin improvement in the coming years.

Bears say

Option Care Health is facing a challenging future due to a significant decline in patient census, lower expected revenue and adjusted EPS, and a shift to lower-margin therapies. While the company has a strong position in the specialty market, it is at risk of being overshadowed by competitors and biosimilar/generic launches. The current stock price may be an opportunity for investors, but there are downside risks such as slowing growth and increased competition, which could limit potential upside. Ultimately, the stock may be fairly valued at this time with the company's targets already reflected in consensus estimates.

OPCH has been analyzed by 10 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 40% recommend Buy, 40% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Option Care Health and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Option Care Health (OPCH) Forecast

Analysts have given OPCH a Buy based on their latest research and market trends.

According to 10 analysts, OPCH has a Buy consensus rating as of Aug 30, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $75.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $75.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Option Care Health (OPCH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.